Details of meeting Scheduled with an Analyst / Institutional Investor
Pfizer Ltd has informed BSE regarding "Details of meeting Scheduled with an Analyst / Institutional Investor".22-09-2016
22-09-2016
Pfizer CEO Ian Read says Hillary Clinton plan to curb drug prices would hurt consumers
Critics of the pharmaceutical industry have long argued that drug makers unfairly raise prices at will, making their products increasingly less accessible to patients.09-09-2016
Lupin gets US FDA nod for antibacterial drug azithromycin suspension
The approved product - azithromycin for oral suspension, 300 mg (100 mg/5 mL) and 1200 mg (200 mg/5 mL) - is the generic version of Pfizer Inc's Zithromax oral suspension01-09-2016
Pfizer to buy antibiotics business from AstraZeneca for $725 mn
Pfizer is buying rights to several of AstraZeneca's experimental and approved antibiotics in global markets outside the US24-08-2016
Pfizer said close to $14 billion deal to acquire Medivation
By acquiring Medivation, Pfizer would gain a blockbuster prostate-cancer treatment, Xtandi, that analysts project will generate $1.33 billion in annual sales by 202022-08-2016
Pfizer plans to bring more global drugs to India
Pfizer plans to introduce more drugs from its global portfolio in India, including injectables from the stable of Hospira which it had acquired last year15-08-2016
Transcript of the tele conference call with the analysts
Pfizer Ltd has submitted to BSE a copy of the transcript of the tele conference call with the analysts held on August 08, 2016.09-08-2016
Pfizer Ltd reply to clarification sought by the exchange
The Exchange had sought clarification from Pfizer Ltd with respect to news appearing in The Economic Times on August 08, 2016 titled "REGULATORS SPOT DEFICIENCIES - Pfizer Halts Production at Chennai Unit."Pfizer Ltd response is enclosed.09-08-2016
Clarification sought from Pfizer Ltd
The Exchange has sought clarification from Pfizer Ltd with respect to news article appearing in The Economic Times on August 08, 2016 titled "REGULATORS SPOT DEFICIENCIES - Pfizer Halts Production at Chennai Unit."The reply is awaited.08-08-2016
Pfizer adds to list of drugmakers under lens for deviating from good manufacturing practices
The USFDA and MHRA submitted their inspection observation reports, which Pfizer said it has reviewed in depth.08-08-2016